Trials / Completed
CompletedNCT01961960
A Study to Evaluate Intramuscular ASP7374
Phase 3 Study of ASP7374 -Open-label Study of Intramuscular ASP7374 in Adults ≥61 Years of Age-
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- UMN Pharma Inc. · Industry
- Sex
- All
- Age
- 61 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate safety and immunogenicity of intramuscular ASP7374 in adults ≥61 years of age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ASP7374 | intramuscular |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2013-10-14
- Last updated
- 2017-09-29
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01961960. Inclusion in this directory is not an endorsement.